NCT04190147

Brief Summary

During recent years, the interest in studying the risks of being born moderate-to-late preterm (MLP), defined as birth between gestational week 32 to 36, has increased. Today the investigators know that morbidity and mortality are significantly higher in these individuals compared to individuals born full-term. However, few studies have focused on the development of the eye in MLP individuals. The purpose of the study is to evaluate eye morphology and visual function in relation to growth, metabolism, blood pressure, neuropsychiatric factors, and quality of life in adolescents born MLP. The results of the examinations will be compared to an age-matched control group. The study will evaluate the structural, functional, and metabolic aspects of the eye with the hypothesis that early eye abnormalities may detect the risk of developing metabolic and cardiovascular diseases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 28, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 9, 2019

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

May 6, 2022

Status Verified

January 1, 2021

Enrollment Period

1.9 years

First QC Date

August 22, 2019

Last Update Submit

May 5, 2022

Conditions

Keywords

Moderate-to-late preterm

Outcome Measures

Primary Outcomes (10)

  • Optic disc area.

    Optic disc area measured with Optical coherence tomography (OCT, Topcon).

    Through study completion, an average of 6 months

  • Visual acuity.

    Visual acuity measured with Early Treatment Diabetic Retinopathy Study (ETDRS) scores.

    Through study completion, an average of 6 months.

  • Blood pressure.

    Systolic and diastolic blood pressure measured with blood pressure cuffs.

    Through study completion, an average of 6 months.

  • Blood concentration of Hemoglobin A1c (HbA1c).

    Blood samples of HbA1c.

    Through study completion, an average of 6 months.

  • Autism Spectrum Screening Questionnaire (ASSQ).

    The ASSQ consists of 27 items and is scored using a likert scale, with the following alternatives: "not true" (0 points), "somewhat true" (1 point) and "certainly true" (2 points).

    Through study completion, an average of 6 months.

  • Pediatric Quality of Life Inventory (PedsQL).

    PedsQL is a questionnaire measuring health-related quality of life in children and adolescents aged 2 to 18 years. It consists of 23 items including physical functioning (8 items), emotional functioning (5 items), social functioning (5 items) and school functioning (5 items). It has a 5-point response scale: "never a problem" (0 points), "almost never a problem" (1 point), "sometimes a problem" (2 points), "often a problem" (3 points), "almost always a problem" (4 points).

    Through study completion, an average of 6 months.

  • Weight.

    Weight measured in kilograms.

    Through study completion, an average of 6 months

  • The Swanson, Nolan, and Pelham Rating Scale (SNAP-IV).

    Screening questionnaire for attention deficit hyperactivity disorder (ADHD) consisting of 26 items rated on a 4-point scale: "not at all" (0 points), "just a little" (1 point), "quite a bit" (2 points) and "very much" (3 points).

    Through study completion, an average of 6 months.

  • Refraction.

    Visual refraction measured with an autorefractor (Topcon).

    Through study completion, an average of 6 months.

  • Height.

    Height measured in meters.

    Through study completion, an average of 6 months.

Study Arms (2)

Moderate-to-late preterm group

Other: Structural, functional and metabolic eye examinations

Full-term group

Other: Structural, functional and metabolic eye examinations

Interventions

Structural, functional and metabolic eye examinations

Full-term groupModerate-to-late preterm group

Eligibility Criteria

Age15 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Year 2002 to 2004, 247 children born moderate-to-late preterm i Gothenburg, Sweden, were enrolled in a prospective, longitudinal and population-based cohort study. These children will be asked to participate in the present follow-up study 15 years later. The age-matched control group born full-term will be recruited from schools in Gothenburg.

You may qualify if:

  • Born moderate-to-late preterm.
  • Born in Gothenburg, Sweden.
  • Born between years 2002 and 2004.

You may not qualify if:

  • Chromosomal abnormalities.
  • Syndromes.
  • Severe malformations.
  • Asphyxia.
  • Language difficulties.
  • Psychosocial problems at birth.
  • Severe maternal illness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of neuroscience and physiology

Gothenburg, Västra Götaland County, SE-413 45, Sweden

Location

MeSH Terms

Conditions

Premature BirthVision DisordersEye Abnormalities

Interventions

Functional Status

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Activities of Daily LivingRehabilitationHealth ServicesHealth Care Facilities Workforce and ServicesHealth StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2019

First Posted

December 9, 2019

Study Start

October 28, 2019

Primary Completion

October 1, 2021

Study Completion

October 1, 2021

Last Updated

May 6, 2022

Record last verified: 2021-01

Locations